Marc Duey, Director at Aprea Therapeutics, Inc. (APRE), bought 30,000 shares at $4.39 ($132K) on 2024-10-16, disclosed to the SEC on 2024-10-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| APRE | BUY | 2024-10-16 | $490 | — | Filing → |